(Q43045807)

English

Clonal analysis of erythroid progenitors suggests that pegylated interferon alpha-2a treatment targets JAK2V617F clones without affecting TET2 mutant cells

scientific article published on 3 June 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Clonal analysis of erythroid progenitors suggests that pegylated interferon alpha-2a treatment targets JAK2V617F clones without affecting TET2 mutant cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

pegylated interferon

1 reference

based on heuristic

inferred from title

Jean-Jacques Kiladjian

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

author name string

A Massé

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

B Cassinat

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

H Mokrani

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

I Teyssandier

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

J-P le Couédic

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

N Cambier

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

C Almire

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

E Pronier

9

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

N Casadevall

10

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

W Vainchenker

11

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

C Chomienne

12

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

F Delhommeau

13

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

French Intergroup of Myeloproliferative Neoplasms (FIM)

14

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

3 June 2010

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1519-1523

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.120

21 January 2018

Mutation in TET2 in myeloid cancers

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.120

21 January 2018

TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.120

21 January 2018

Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.120

21 January 2018

Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.120

21 January 2018

Pegylated interferon alfa-2a yields high rates of hematologic and molecular response in patients with advanced essential thrombocythemia and polycythemia vera

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.120

21 January 2018

A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.120

21 January 2018

Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.120

21 January 2018

The JAK2 617V>F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.120

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LEU.2010.120

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43045807&oldid=2205765627"